Thursday - May 26, 2022
Senate Health Committee Issues Testimony From Biotechnology Innovation Organization Chief Scientific Officer Esham
May 03, 2022
WASHINGTON, May 3 -- The Senate Health, Education, Labor and Pensions Committee issued the following testimony by Cartier Esham, chief scientific officer at the Biotechnology Innovation Organization, involving a hearing on April 5, 2022, entitled "FDA User Fee Agreements: Advancing Medical Product Regulation and Innovation for the Benefit of Patients".

The FDA is the Food and Drug Administration.

* * *

My name is Cartier Esham, and I am the Chief . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products